Farther Finance Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
CIM
GI
EFG
LHWM
VCM
MGI
CI
MPWT
CA
EWP
Farther Finance Advisors's CRL Position: Q3 2026 in Review
Farther Finance Advisors increased its Charles River Laboratories (CRL) stake by 136% in Q3 2026, buying an estimated $351K and bringing the position to 2,311 shares worth $682K. The position accounts for ﹤0.01% of the portfolio, ranked #1359.
Farther Finance Advisors first reported a position in CRL in Q4 2022 and has held it in 16 quarters since. 15 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Farther Finance Advisors held 2,311 shares of Charles River Laboratories worth $682K as of Q3 2026.
- Farther Finance Advisors bought 1,332 Charles River Laboratories shares in Q3 2026, an estimated $351K.
- Charles River Laboratories made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1359 holding.
- Farther Finance Advisors first reported a position in Charles River Laboratories in Q4 2022 and has held it in 16 quarters since.
- 15 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.